ESC Premium Access

Combination therapy in CV risk reduction: what are we waiting for in dyslipidaemia management?

Congress Presentation

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
65 presentations
10 followers

3 more presentations in this session

To be or not to be…but at which goal?

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Thumbnail

LDL-C reducing agents; what genetic tells us

Speaker: Professor B. Ference (Cambridge, GB)

Thumbnail

Getting to goals cost effectively, how can we make a difference?

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Access the full session

Hypercholesterolemia management - What will be our options after tomorrow?

Speakers: Professor P. Steg, Professor L. Tokgozoglu, Professor B. Ference, Professor E. Stroes
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb